Simvastatin Potentiates the Antihyperglycemic, Antidyslipidimic and Antioxidative Effect of Glibenclamide on Alloxan-Induced Diabetic Rats


The aim of the current study is to investigate the effect of combination of glibenclamide; an antidiabetic drug and simvastatin; a HMG-CoA reductase inhibitor on long-term (four weeks) alloxan-induced diabetes rats (ADRs). Methods: Alloxan (120 mg/kg body weight, BW) was injected intra-peritonially (i.p.) in rats. At first alloxan (120 mg/kg BW) induced diabetic rats were treated with single dose of glibenclamide (1.2 mg/70kg BW) and simvastatin (10 mg/70kg BW) for two weeks. Then fixed dose combinations of glibenclamide (0.6 mg/70kg BW) and simvastatin (5 mg/70kg BW) were injected along with those of two drugs for four weeks. Results: At first it was found that glibenclamide reduced significant amount of glucose in blood, but it had no significant effect on lipid profile on short term (two weeks) ADRs. In contrast, simvastatin had no effect on blood glucose level, whereas it significantly reduced total cholesterol (TC), triglycerides (TG) and low density lipoprotein cholesterol (LDL-C) and increased significant amount of high density lipoprotein cholesterol (HDL-C). However, pathological changes of pancreas’s Islets of Langerhans were observed only after long-term (four weeks) induction of alloxan in rats. The inhibitory effect of combination therapy on blood glucose, TC, TG and LDL-C level was higher than those of monotherapy alone on long term ADRs. In addition, treatment with combination therapy on long term ADRs showed higher amount of HDL-C level and super oxide dismutase and catalase enzyme activity than those with monotherapy. They also decreased serum glutamic pyruvic transaminase (SGPT) and Serum glutamic oxaloacetic transaminase (SGOT) level. Administration of simvastatin recovered Langerhans cells from shrinkage whereas glibenclamide displayed slight recovery. But the combination therapy showed complete recovery of Langerhans cells as compared with diabetic rats. Conclusion: Our present findings suggest that treatment of glibenclamide in combination with simvastatin may be more effective than mono-therapy for preventing diabetes in rats. It may also suggest that this combination may have some beneficial effects on reducing cardiovascular risks from long term diabetes in rats.

Share and Cite:

Begum, M. , Rahman, A. , Islam, S. , Asaduzzaman, M. , Ali, H. , Ali, Y. , Zannah, S. , Khurshid Alam, A. , Rahman, A. and Rashid, M. (2014) Simvastatin Potentiates the Antihyperglycemic, Antidyslipidimic and Antioxidative Effect of Glibenclamide on Alloxan-Induced Diabetic Rats. Pharmacology & Pharmacy, 5, 1059-1069. doi: 10.4236/pp.2014.511115.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Albajali, A.A., Nagi, A.H., Shahzad, M., Ullah, M.I. and Hussain, S. (2011) Effect of Allium sativa L. on Pancreatic β. Cells Incomparison to Nigella sativa L. in Streptozotocin Induced Diabetic Rats. Journal of M-Medicinal Plants Research, 5, 5779-5784.
[2] Pennathur, S. and Heinecke, J.W. (2007) Mechanisms for Oxidative Stress in Diabetic Cardiovascular Disease. Antioxidants and Redox Signaling, 9, 955-969.
[3] Natheer, H.A. (2011) Oxidative Stress, Antioxidant Status and Lipid Profile in the Saliva of Type 2 Diabetics. Diabetes and Vascular Disease Research, 8, 22-28.
[4] Amira, A.M.A. (2010) Oxidative Stress and Disease. Research Journal of Immunology, 3, 129-145.
[5] Samson, F.E. and Nelson, S.R. (2000) The Aging Brain, Metals and Oxygen Free Radicals. Cellular and Molecular Biology, 46, 699-707.
[6] Genet, S., Kale, R.K. and Baquer, N.Z. (2002) Alterations in Antioxidant Enzymes and Oxidative Damage in Experimental Diabetic Rat Tissues: Effect of Vanadate and Fenugreek (Trigonellafoenum graecum). Molecular Cellular Biochemistry, 236, 7-12.
[7] McKenney, J.M. (2001) Pharmacotherapy of Dyslipidemia. Cardiovascular Drugs and Therapy, 15, 413-422.
[8] Yang, R., Sh,i Y., Hao, G., Li, W. and Le, G. (2008) Increasing Oxidative Stress with Progressive Hyperlipidemia in Human: Relation between Malondialdehyde and Atherogenic Index. Journal of Clinical Biochemistry and Nutrition, 43,154-158.
[9] Asadujjaman, M., Hossain, M.S., Khan, M.R.I., Anisuzzaman, A.S.M., Ahmed, M. and Islam, A. (2011) Antihyperglycemic and Glycogenesis Effects of Different Fractions of Brassica oleracea in Alloxan Induced Diabetic Rats. International Journal Pharmaceutical Science and Research, 2, 1436-1442.
[10] Malviya, N., Jain, S. and Malvia, S. (2010) Antidiabetic Potential of Medicinal Plants. Acta Poloniae Pharmaceutica-Drug Research, 6, 7113-7118.
[11] Matafome, P., Louro, T., Rodriques, L., Crisostomo, J., Nunes, E., Amaral, C., Monterio, P., Cipriano, A. and Seica, R. (2011) Metformin and Atorvastatin Combination Further Protect the Liver in Type 2 Diabetes with Hyperlipidaemia. Diabetes/Metabolism Research and Reviews, 27, 54-62.
[12] Sinha, A.K. (1972) Colorimetric Assay of Catalase. Analytical Biochemistry, 47, 389-394.
[13] Misra, H.P. and Fridovich, I. (1972) The Role of Superoxide Anion in the Auto Oxidation of Epinephrine and a Simple Assay for Superoxide Dismutase. Journal of Biological Chemistry, 247, 3170-3175.
[14] Aronson, D. (2008) Hyperglycemia and the Pathobiology of Diabetic Complications. Advances in Cardiology, 45, 1-16.
[15] Aqil, S., Jaleel, A., Jaleel, F. and Basir, F. (2008) Comparison of Adiponectin in Ischemic Heart Disease versus Ischemic Stroke in Diabetic Patients. World Applied Science Journal, 3, 759-762.
[16] Vadivelan, R., Umasankar, P., Dipanjan, M., Dhanabal, S.P., Shanish, A., Satishkumar, M.N. and Elanko, K. (2011) Antidiabetic Activity of Madhumega Churanam (Siddha Formulation) in Alloxan Induced Diabetic Rats. Der Pharmacia Sinica, 2, 299-304.
[17] Anitha, N., Rao, J.V., Kavimani, S. and Himabindu, V. (2008) Pharmacodynamic Drug Interaction of Metformin with Statins in Rats. Journal of Pharmacology and Toxicology, 3, 408-413.
[18] Balasubramanian, R., Varadharajan, S., Kathale, A., Nagraj, L.M., Periyandavar, I., Nayak, U.P., Sharma, A., Bolmall, C. and Baliga, V.P. (2008) Assessment of the Efficacy and Tolerability of a Fixed Dose Combination of Atorvastatin 10 mg plus Metformin SR 500 mg in Diabetic Dyslipidaemia in Adult Indian Patients. Journal of the Indian Medical Association, 106, 464-467.
[19] Jenkins, D.J.A., Jenkins, A.L., Wolever, T.M.S., Vuksan, V. and Rao, A.V. (1995) Effect of Reduced Rat of Carbohydrate Absorption on Carbohydrate and Lipid Metabolism. European Journal of Clinical Nutrition, 49, S68-S73.
[20] Iams, S.G. and Wexler, B.C. (1997) Alloxan Diabetes in Spontaneously Hypertensive Rats: Gravimetric, Metabolic and Histopathological Alterations. British Journal of Experimental Pathology, 58, 177-199.
[21] Sharma, S.R., Dwivedi, S.K. and Swarup, D. (1996) Hypoglycaemic and Hypolipidaemic Effects of Cinnamomum tamala Nees Leaves. Indian Journal of Experimental Biology, 34, 372-374.
[22] Rajasekaran, A. and Kalaivani, M. (2011) Antioxidant Activity of Aqueous Extract of Monascus Fermented Indian Variety of Rice in High Cholesterol Diet Fed-Streptozotocin Diabetic Rats, an in Vivo Study. The International Journal of Current Scientific Research, 1, 35-38.
[23] Turko, I.V., Marcondes, S. and Murad, F. (2001) Diabetes Associated Nitration of Tyrosine and Inactivation of Succinyl-CoA: 3-Oxoacid CoA-Transferase. American Journal of Physiology Heart and Circulatory Physiology, 281, 2289-2294.
[24] Rosen, F., Roberts, N.R. and Nichol, C.A. (2007) Glucocorticosteroids and Transaminase Activity. I. Increased Activity of Glutamic Pyruvic Transaminase in Four Conditions Associated with Gluconeogenesis. Journal of Biological Chemistry, 234. 476-480.
[25] Day, C.P. (2002) Pathogenesis of Steatohepatitis. Best Practice and Research Clinical Gastroenterology, 16, 663-678.
[26] Singh, N. and Gupta, M. (2007) Regeneration of Beta Cells in Islets of Langerhans of Pancreas of Alloxan Diabetic Rats by Acetone Extract of Momordica charantia (Linn.) (Bitter Gourd) Fruits. Indian Journal of Experimental Biology, 45, 1055-1062.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.